The new Board of Directors has appointed Didier Hoch as Chairman and CEO, and Thibaut du Fayet as Deputy CEO Regulatory News: Pherecydes Pharma (FR0011651694 ALPHE, éligible PEA-PME) (Paris:ALPHE)
Teleperformance: Combined Shareholders Meeting of April 22, 2021
Regulatory News:
Teleperformance SE s (Paris:TEP) Combined General Meeting was held on April 22, 2021 in Paris under the chairmanship of Olivier Rigaudy, deputy CEO of the group.
Shareholders adopted all the resolutions submitted to their vote.
The shareholders notably approved:
the 2020 parent company and consolidated financial statements;
the proposed dividend of €2.40 per share, unchanged compared with the previous year: the ex-dividend date is April 27, 2021 and the payment date is April 29, 2021;
the renewal of the terms of office of five directors: Emily Abrera, Daniel Julien, Alain Boulet, Robert Paszczak and Stephen Winningham. These renewals will maintain the balanced representation of men and women on the Board, as well as the requisite diversity in terms of experience, expertise, and nationalities. The board of Directors renewed Daniel Julien as Chairman and Chief Executive Officer;